COVID-19 | Moderna Inc said it will apply for US and European emergency authorisation of its Covid-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1 percent effective with no serious safety concerns.

It also reported a 100 percent success rate in preventing severe cases. The filing sets Moderna's product up to be the second vaccine likely to receive US emergency use authorisation this year...